A Study to Evaluate Efficacy and Safety of Lifitegrast in Subjects With Dry Eye (OPUS-3)
NCT02284516
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
711
Enrollment
INDUSTRY
Sponsor class
Conditions
Dry Eye Disease
Interventions
DRUG:
Lifitegrast
DRUG:
Placebo
Sponsor
Shire